ENDONOVO THERAPEUTICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
ENDONOVO THERAPEUTICS, INC. (ENDV) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $17.36 million as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2023-04-17
- 2022-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $17.36M.
- 2021-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $3.44M.
- 2020-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.20M.
- 2019-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $10.60M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2022-12-31 | $17.36M 10-K · filed 2023-04-17 |
| 2021-12-31 | $3.44M 10-K · filed 2023-04-17 |
| 2020-12-31 | $4.20M 10-K · filed 2023-04-17 |
| 2019-12-31 | $10.60M 10-K · filed 2022-04-14 |